[ Price : $8.95]
FDA commissioner Marty Makary discusses upcoming actions to encourage more prescription-to-over-the-counter drug switches.[ Price : $8.95]
Cogent Biosciences says FDA has agreed to accept the companys planned NDA for cancer drug bezuclastinib under the agencys Real-Tim...[ Price : $8.95]
IntraBio reports positive results from a pivotal Phase 3 clinical trial showing that levacetylleucine significantly improved neuro...[ Price : $8.95]
FDA says its new ImportShield program improved processing speed and volume capacity while reducing staff hours in its first four m...[ Price : $8.95]
Advanced Medical Technology Association urges FDA to narrow and clarify a draft guidance on quality management system information,...[ Price : $8.95]
Moderna and Merck report updated five-year follow-up data that show their personalized mRNA cancer vaccine candidate, intismeran a...[ Price : $8.95]
FDA asks Capricor Therapeutics for a full clinical study report from the companys Phase 3 HOPE-3 trial as part of its ongoing BLA ...[ Price : $8.95]
FDA publishes for review and comment the International Council for Harmonization M4Q(R2) guidance establishing the location and st...